EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Cerebrovascular and Bleeding Outcomes of Warfarin versus Direct Oral Anticoagulants Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abeer A Alomairi iD, Rana Alduhaysh, Alaa Samandar, Abeer Alshehri, Ghada AlAbdullah, Saud Almutairi, Faisal Althekair

Neurosciences · 26.06.2026 · 31 (3) · 193-206

DOI: 10.17712/1658-3183.2800 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurosciences, online erschienen am 26.06.2026. Verfasst von Abeer A Alomairi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Warfarin, Atrial Fibrillation, Anticoagulants, Hemorrhage. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the effects on cerebral health in atrial fibrillation patients receiving either warfarin or direct oral anticoagulants (DOACs). Atrial fibrillation is linked to a higher likelihood of both stroke and cognitive impairment. While warfarin has historically served as the leading anticoagulant treatment, DOACs are now more frequently viewed as alternatives with an improved safety profile.

Methods

The methodology involved an extensive search of multiple databases, completed up to June 2024. This search yielded randomized controlled trials, which together enrolled over 60,000 participants between the ages of 70 and 84. The DOACs studied were dabigatran, rivaroxaban, apixaban, and edoxaban, given in various dosages. Warfarin was administered with dose adjustments to keep the international normalized ratio within a target range of 2.0 to 3.0.

Results

With a relative risk of 0.81 (95% CI, p < 0.00001; I2 = 19%), the results showed that 20 high-dose DOACs considerably decreased the risk of stroke when compared to warfarin. However, there were no discernible variations for major bleeding (relative risk 0.89), moderate bleeding (relative risk 0.92), or cardiovascular events (relative risk 0.96).

Conclusion

The DOACs are frequently more efficacious than warfarin in avoiding stroke and systemic embolism in patients with non-valvular atrial fibrillation. A significant decline in hemorrhagic stroke was the main cause of the pooled data's 19% relative risk reduction in stroke or systemic embolism. While bleeding outcomes varied among the individual DOACs, the overall findings support their favorable risk-benefit profile. Compared to warfarin, DOACs consistently showed fewer intracranial hemorrhages and a more favorable bleeding profile. These results support prioritizing DOACs in clinical practice, given their enhanced safety and reduced mortality rates. However, due to differences in bleeding risks among DOACs, treatment decisions should be tailored to individual patient factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinAtrial FibrillationAnticoagulantsHemorrhageStrokeHumansRandomized Controlled Trials as TopicAdministration, Oral

Stichwörter der Autor:innen

ApixabanBleedingDabigatranStrokeWarfarin

Substanzen

WarfarinAnticoagulants

Autor:innen und Institutionen

  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
  • Al-Qunfudah College of Medicine, Umm AlQura University, Mecca, Kingdom of Saudi Arabia.
  • College of Medicine, University of Jeddah, Jeddah, Kingdom of Saudi Arabia.
  • Division of Neurology, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia.

ORCID-Profile: Abeer A Alomairi

Zitieren

APA

Alomairi, A. A., Alduhaysh, R., Samandar, A., Alshehri, A., AlAbdullah, G., Almutairi, S., & Althekair, F. (2026). Cerebrovascular and Bleeding Outcomes of Warfarin versus Direct Oral Anticoagulants Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Neurosciences, 31(3), 193-206. https://doi.org/10.17712/1658-3183.2800

Vancouver

Alomairi AA, Alduhaysh R, Samandar A, Alshehri A, AlAbdullah G, Almutairi S, et al. Cerebrovascular and Bleeding Outcomes of Warfarin versus Direct Oral Anticoagulants Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Neurosciences. 2026;31(3):193-206. doi:10.17712/1658-3183.2800

BibTeX
@article{Alomairi2026,
  author = {Alomairi, Abeer A and Alduhaysh, Rana and Samandar, Alaa and Alshehri, Abeer and AlAbdullah, Ghada and Almutairi, Saud and Althekair, Faisal},
  title = {Cerebrovascular and Bleeding Outcomes of Warfarin versus Direct Oral Anticoagulants Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Neurosciences},
  year = {2026},
  volume = {31},
  number = {3},
  pages = {193--206},
  doi = {10.17712/1658-3183.2800}
}
Kostenlos starten →